TLDR GIS closed at $49.18 on Sept. 17, down 0.77% after Q1 results. Q1 net sales fell 7% to $4.5B, with organic sales down 3%. Adjusted EPS of $0.86 topped estimates but dropped 20% YoY. CEO Jeff Harmening highlights innovation and pet food launch. Full-year outlook reaffirmed, but tariffs seen as a key risk. General [...] The post General Mills, Inc. ($GIS) Stock: Q1 Results Beat Estimates but Sales Decline appeared first on CoinCentral.TLDR GIS closed at $49.18 on Sept. 17, down 0.77% after Q1 results. Q1 net sales fell 7% to $4.5B, with organic sales down 3%. Adjusted EPS of $0.86 topped estimates but dropped 20% YoY. CEO Jeff Harmening highlights innovation and pet food launch. Full-year outlook reaffirmed, but tariffs seen as a key risk. General [...] The post General Mills, Inc. ($GIS) Stock: Q1 Results Beat Estimates but Sales Decline appeared first on CoinCentral.

General Mills, Inc. ($GIS) Stock: Q1 Results Beat Estimates but Sales Decline

2025/09/18 20:31
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • GIS closed at $49.18 on Sept. 17, down 0.77% after Q1 results.
  • Q1 net sales fell 7% to $4.5B, with organic sales down 3%.
  • Adjusted EPS of $0.86 topped estimates but dropped 20% YoY.
  • CEO Jeff Harmening highlights innovation and pet food launch.
  • Full-year outlook reaffirmed, but tariffs seen as a key risk.

General Mills, Inc. ($GIS) closed at $49.18 on September 17, 2025, following the release of its fiscal first-quarter 2026 results.

General Mills, Inc. (GIS)

The company reported revenue of $4.5 billion, down 7% from last year, and adjusted earnings per share (EPS) of $0.86, which was 20% lower year over year but ahead of analyst estimates of $0.81. Reported diluted EPS surged 116% to $2.22, driven by a $1.05 billion gain from the U.S. yogurt divestiture.

Operating profit more than doubled to $1.7 billion, while adjusted operating profit fell 18% in constant currency to $711 million. Gross margin declined 90 basis points to 33.9% of net sales due to higher input costs, while adjusted gross margin fell 120 basis points to 34.2%.

Segment Performance

In North America Retail, net sales dropped 13% to $2.6 billion, including an 8-point headwind from yogurt divestitures. Organic sales were down 5%, and segment operating profit declined 24% to $564 million. Despite this, the company gained or held pound share in eight of its top ten U.S. categories.

North America Pet revenue rose 6% to $610 million, helped by the Whitebridge Pet Brands acquisition, though organic sales slipped 5%. Operating profit decreased 5% to $113 million as the company invested in marketing and product innovation, including the fresh pet food rollout.

In Foodservice, sales fell 4% to $517 million, but organic sales rose 1% thanks to strong cereal and biscuit performance. International sales climbed 6% to $760 million, with organic growth of 4%, led by India, North Asia, and Europe. Operating profit improved to $66 million from $21 million a year earlier.

Strategic Initiatives

CEO Jeff Harmening stressed the company’s focus on restoring organic growth through innovation, advertising campaigns, and in-store events. A key initiative is Blue Buffalo’s launch into the U.S. fresh pet food market, which is set to expand in the second quarter.

General Mills continues to pursue efficiency through its Holistic Margin Management program and a global transformation initiative, targeting $100 million in savings. These savings are expected to offset some of the headwinds from tariffs and higher input costs.

Fiscal 2026 Outlook

General Mills reaffirmed its full-year guidance, projecting organic net sales growth between -1% and +1%. Adjusted operating profit and EPS are expected to fall 10% to 15% in constant currency. The company warned that tariffs and higher input costs will pressure margins, but it expects long-term growth to improve with continued investment in brand innovation and market share expansion.

Performance Overview

GIS stock has struggled relative to the S&P 500. Year-to-date, shares are down 20.35%, while the index gained 12.22%. Over one year, GIS fell 31.25%, compared to the S&P 500’s 17.14% rise. The five-year return stands at just 1.10%, versus the index’s 96.61% growth.

 

The post General Mills, Inc. ($GIS) Stock: Q1 Results Beat Estimates but Sales Decline appeared first on CoinCentral.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

TLDR Elliott Investment Management has built a multibillion-dollar stake in Synopsys (SNPS), per the WSJ. The activist firm wants Synopsys to generate more revenue
Share
Coincentral2026/03/23 17:00
Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

BitcoinWorld Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale Global energy markets face a sobering reality in 2025
Share
bitcoinworld2026/03/23 17:05
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11